跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RETAXIME - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
RETAXIME
Approved
STANDARD
RETAXIME
J.M. Tolmann Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b621e0c693650667
Company
J.M. Tolmann Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
b621e0c693650667
Drug Approval Philippines Name
RETAXIME
Product Name
RETAXIME
Registration Number
DRP-5683-04
Brand Name
RETAXIME
Generic Name
CEFIXIME
Dosage Form
Granules For Suspension (Oral Drops)
Dosage Strength
20mg/mL
Manufacturer
J.M. Tolmann Laboratories, Inc.
Distributor
Reta Drug
Issuance Date
29 February 2024
Expiry Date
20 February 2029
Pharmacologic Category
ANTIBACTERIAL (CEPHALOSPORIN)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b621e0c693650667
Type
Standard
Back to Philippines FDA Approvals